After gains of 4.5% this afternoon, Surgery Partners shares are now trading at $39.4. Read below for the essential facts about this stock:
-
Surgery Partners has logged a -24.8% 52 week change, compared to -3.3% for the S&P 500
-
SGRY has an average analyst rating of buy and is -13.79% away from its mean target price of $45.7 per share
-
Its trailing earnings per share (EPS) is $-0.61, which brings its trailing Price to Earnings (P/E) ratio to -64.6. The Health Care sector's average P/E ratio is 24.45
-
The company's forward earnings per share (EPS) is $0.85 and its forward P/E ratio is 46.4
-
The company has a Price to Book (P/B) ratio of 2.5 in contrast to the Health Care sector's average P/B ratio is 4.16
-
The current ratio is currently 1.9, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
The company's free cash flow for the last fiscal year was $78,200,000.00 and the average free cash flow growth rate is 8.8%
-
Surgery Partners's revenues have an average growth rate of 8.5% with operating expenses growing at 7.0%. The company's current operating margins stand at 14.2%